CL-218.872 CN Esportazione - Commercio all'ingrosso

200 - 2500

Discover CL-218,872 – The Next Generation Sedative

Introduzione CL-218,872, a groundbreaking sedative-hypnotic offering unparalleled efficacy in inducing sleep and reducing anxiety. Unlike traditional benzodiazepines, CL-218,872 targets specific GABA A receptors, ensuring a focused approach with fewer side effects. Ideal for research and therapeutic applications, it’s a beacon of hope for those seeking reliable and safe sedation.

Tutti i prodotti di CN Export - Wholesale vengono spediti dalla Cina.

In case of loss or seize by local customs: NO REFUNDS nor COMPLAINTS.

Tutte le droghe di design vendute su questo sito sono destinate alla ricerca e alle applicazioni forensi.

Product Overview:

CL-218,872 is a novel sedative and hypnotic compound. Unlike traditional benzodiazepines, it belongs to a unique class of nonbenzodiazepine hypnotics. The compound is particularly noted for its selective action on the GABA A receptor, specifically targeting the α1 subtype.

Chemical and Pharmacological Properties:

The molecular structure of CL-218,872 differentiates it from benzodiazepines, contributing to its unique pharmacological profile. Its action as a partial agonist at the GABA A receptor sites leads to sedative, anxiolytic, anticonvulsant, and amnestic effects, with a reduced risk of dependency compared to traditional benzodiazepines.

Dosaggio e somministrazione:

The optimal dosage of CL-218,872 varies depending on the intended use and the subject’s physiology. In research settings, dosages are carefully controlled and monitored.

Therapeutic Effects:

CL-218,872 is primarily used in research for its sedative and hypnotic effects. It has shown potential in studies for inducing sleep and reducing anxiety, with a faster onset and shorter duration of action, making it advantageous for specific therapeutic applications.

Side Effects and Harm Reduction:

Like all sedative-hypnotics, CL-218,872 can cause side effects such as dizziness, confusion, and motor impairment. Long-term use or misuse can lead to tolerance and dependence. Its safety profile, however, indicates a lower risk of these adverse effects compared to traditional benzodiazepines. Harm reduction strategies involve controlled administration, monitoring for adverse reactions, and avoiding use with other central nervous system depressants.

Comparative Analysis:

In comparison to other hypnotics like triazolam or zolpidem, CL-218,872 offers a unique balance of efficacy and safety, making it a subject of interest in both pharmacological research and potential clinical use.

Perché acquistare CL-218,872 Esportazione CN da RECHEMCO?

★ Abbiamo una lunga storia commerciale sul mercato e quindi potete beneficiare della nostra esperienza.
★ CL-218,872 è stato testato e verificato.
Accettiamo diversi metodi di pagamento come Bitcoin, Monero e bonifico bancario.

Cosa riceverete con l'acquisto CL-218,872 CN Export da RECHEMCO?

- Un sacchetto sigillato in foglio di alluminio contenente il massimo livello di qualità. CL-218,872 CN Export
• White powder
• 98-99% Purity

Quantità

5g, 10g, 25g, 50g, 100g, 250g

Recensioni

Ancora non ci sono recensioni.

Recensisci per primo “CL-218,872 CN Export – Wholesale”

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

RUOTA PER VINCERE!

  • Tentate la fortuna e vincete un codice coupon di sconto
  • 1 free spin ogni 15 giorni
  • Non barare! Si prega di utilizzare solo il proprio indirizzo e-mail reale.
  • RICORDA: la validità del codice coupon è di 7 giorni.
Tentate la fortuna!
Mai
Ricorda più tardi
No grazie